Relationship between history of hormonal contraceptive use and anaemia status among women in sub-Saharan Africa: A large population-based study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
10
01
2023
accepted:
14
05
2023
medline:
16
6
2023
pubmed:
14
6
2023
entrez:
14
6
2023
Statut:
epublish
Résumé
Anaemia among women has been reported to be a significant contributor to hemorrhage, exacerbated risk of stillbirths, miscarriages, and maternal mortalities. Hence, understanding the factors associated with anaemia is imperative to develop preventive strategies. We examined the association between history of hormonal contraceptive use and risk of anaemia among women in sub-Saharan Africa. We analyzed data from the recent Demographic and Health Surveys (DHS) of sixteen countries in sub-Saharan Africa. Countries with recent DHSs conducted from 2015 to 2020 were included in the study. A total of 88,474 women of reproductive age were included. We used percentages to summarize the prevalence of hormonal contraceptives and anaemia among women of reproductive age. We used multilevel binary logistic regression analysis to examine the association between hormonal contraceptives and anaemia. We presented the results using crude odds ratio (cOR) and adjusted odds ratios (aOR), with their respective 95 percent confidence intervals (95% CIs). On the average, 16.2% of women are using hormonal contraceptives and this ranged from 7.2% in Burundi to 37.7% in Zimbabwe. The pooled prevalence of anaemia was 41%, ranging from 13.5% in Rwanda to 58.0% in Benin. Women who used hormonal contraceptives were less likely to be anaemic compared to those who were not using hormonal contraceptives (aOR = 0.56; 95%CI = 0.53, 0.59). At the country-level, hormonal contraceptive use was associated with a reduced likelihood of anaemia in 14 countries, except for Cameroon and Guinea. The study underscores the importance of promoting the use of hormonal contraceptives in communities and regions that have a high burden of anaemia among women. Specifically, health promotion interventions aimed at promoting the use of hormonal contraceptives among women must be tailored to meet the needs of adolescents, multiparous women, those in the poorest wealth index, and women in union as these sub-populations were at significantly higher risk of anaemia in sub-Saharan Africa.
Sections du résumé
BACKGROUND
Anaemia among women has been reported to be a significant contributor to hemorrhage, exacerbated risk of stillbirths, miscarriages, and maternal mortalities. Hence, understanding the factors associated with anaemia is imperative to develop preventive strategies. We examined the association between history of hormonal contraceptive use and risk of anaemia among women in sub-Saharan Africa.
METHODS
We analyzed data from the recent Demographic and Health Surveys (DHS) of sixteen countries in sub-Saharan Africa. Countries with recent DHSs conducted from 2015 to 2020 were included in the study. A total of 88,474 women of reproductive age were included. We used percentages to summarize the prevalence of hormonal contraceptives and anaemia among women of reproductive age. We used multilevel binary logistic regression analysis to examine the association between hormonal contraceptives and anaemia. We presented the results using crude odds ratio (cOR) and adjusted odds ratios (aOR), with their respective 95 percent confidence intervals (95% CIs).
RESULTS
On the average, 16.2% of women are using hormonal contraceptives and this ranged from 7.2% in Burundi to 37.7% in Zimbabwe. The pooled prevalence of anaemia was 41%, ranging from 13.5% in Rwanda to 58.0% in Benin. Women who used hormonal contraceptives were less likely to be anaemic compared to those who were not using hormonal contraceptives (aOR = 0.56; 95%CI = 0.53, 0.59). At the country-level, hormonal contraceptive use was associated with a reduced likelihood of anaemia in 14 countries, except for Cameroon and Guinea.
CONCLUSION
The study underscores the importance of promoting the use of hormonal contraceptives in communities and regions that have a high burden of anaemia among women. Specifically, health promotion interventions aimed at promoting the use of hormonal contraceptives among women must be tailored to meet the needs of adolescents, multiparous women, those in the poorest wealth index, and women in union as these sub-populations were at significantly higher risk of anaemia in sub-Saharan Africa.
Identifiants
pubmed: 37315029
doi: 10.1371/journal.pone.0286392
pii: PONE-D-23-00819
pmc: PMC10266693
doi:
Substances chimiques
Contraceptive Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0286392Informations de copyright
Copyright: © 2023 Aboagye et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Obstet Gynecol Neonatal Nurs. 2017 May - Jun;46(3):e56-e64
pubmed: 28286075
Phys Sportsmed. 2023 Jun;51(3):217-222
pubmed: 34991413
Sex Reprod Healthc. 2017 Oct;13:97-102
pubmed: 28844365
PLoS One. 2020 Sep 11;15(9):e0238957
pubmed: 32915880
BMC Public Health. 2019 Dec 30;19(1):1757
pubmed: 31888579
Public Health. 2006 Sep;120(9):795-804
pubmed: 16824562
Arch Public Health. 2021 Nov 29;79(1):214
pubmed: 34839822
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
PLoS One. 2021 Mar 25;16(3):e0248969
pubmed: 33765048
BMC Pregnancy Childbirth. 2022 Jun 13;22(1):478
pubmed: 35698085
BMC Public Health. 2020 Mar 29;20(1):405
pubmed: 32223749
Trop Med Int Health. 2013 Dec;18(12):1488-97
pubmed: 24118432
BMC Public Health. 2019 Dec 11;19(1):1662
pubmed: 31829161
BMC Pregnancy Childbirth. 2011 Jan 20;11:7
pubmed: 21251269
Reprod Health. 2021 Jun 21;18(1):128
pubmed: 34154598
Lancet Glob Health. 2013 Jul;1(1):e16-25
pubmed: 25103581
Cochrane Database Syst Rev. 2019 Feb 11;2:CD000154
pubmed: 30742315
BMJ Sex Reprod Health. 2018 Nov 21;:
pubmed: 30463847
JAMA Netw Open. 2022 Jan 4;5(1):e2143730
pubmed: 35029663
WHO South East Asia J Public Health. 2018 Sep;7(2):107-113
pubmed: 30136669
Lancet Glob Health. 2018 May;6(5):e548-e554
pubmed: 29571592
Biomed Res Int. 2021 Nov 03;2021:9912549
pubmed: 34778462
Obstet Gynecol. 2003 Apr;101(4):653-61
pubmed: 12681866
PLoS One. 2022 May 9;17(5):e0268129
pubmed: 35533194
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
Ann N Y Acad Sci. 2008;1136:161-71
pubmed: 17954679
J Blood Med. 2020 Sep 07;11:279-287
pubmed: 32982526
Int J Epidemiol. 2012 Dec;41(6):1602-13
pubmed: 23148108
Contraception. 2003 Jan;67(1):1-8
pubmed: 12521650
Lancet Glob Health. 2018 May;6(5):e479-e480
pubmed: 29571593